Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2
- Conditions
- Diabetes MellitusLocal Anesthesia
- Interventions
- Drug: L+C maxillary anesthesiaDrug: L+C mandibular anesthesiaDrug: L+E maxillary anesthesiaDrug: L+E mandibular anesthesia
- Registration Number
- NCT02371759
- Lead Sponsor
- University of Belgrade
- Brief Summary
The purpose of this study is to determine whether 2% lidocaine (L) + clonidine (C) (15 mcg/ml) as a vasoconstrictor achieves efficient (equal or better parameters of intraoral local anesthesia in comparison to 2% lidocaine + epinephrine (E) (1:80 000)) and safe (stable cardiovascular parameters - systolic, diastolic, mean blood pressure and heart rate) intraoral local anesthesia in patients with Diabetes mellitus type 2.
- Detailed Description
Patients with diabetes mellitus type 2, represent a risk for performing regional anesthesia techniques due to microvascular (microangiopathy, neuropathy) and macrovascular (hypertension, coronary heart disease) complications. There is evidence that local anesthetic toxicity may be increased in diabetic setting due to underlying neuropathy; while interaction of diabetic blood vessels with vasoconstrictors may be of importance because of microangiopathic changes. Lately, regional anesthesia protocol in general surgery for patients with diabetes mellitus was released, proposing reduction of local anesthetic concentration and avoiding epinephrine as vasoconstrictor.
Oral cavity tissues in diabetes mellitus also suffer from neuropathy (burning, paresthesia, teeth loss, temporomandibular dysfunction, xerostomia) and microangiopathy (periodontal disease, salivary gland dysfunction). Most widely used vasoconstrictor for intraoral local anesthesia, epinephrine, is an alpha- and beta- adrenergic agonist. Because of its beta-adrenergic effects, epinephrine could adversely affect cardiovascular function, especially in risk patients. There are data suggesting that intraoral local anesthesia obtained with 2% lidocaine with clonidine, selective alpha 2-adrenoceptor agonist as a vasoconstrictor, is characterized with significantly more stable cardiovascular parameters and similar parameters of local anesthesia with respect to lidocaine with epinephrine in healthy and hypertensive patients.
With regard to aforementioned, the aim of this randomized double-blind controlled clinical trial is to evaluate and compare efficacy and safety of intraoral local anesthesia obtained with 2% lidocaine (L) + clonidine (15 mcg/ml) (C) or 2% L + epinephrine (1:80 000) (E), comparing healthy and diabetes mellitus type 2 patients. Prior to tooth extraction, random allocation to one of four groups (L+C maxillary infiltration, L+C mandibular block, L+E maxillary infiltration and L+E mandibular block) is performed for diabetic (30 per group) and healthy (30 per group) patients. Parameters of local anesthesia (onset, duration, intensity, width of anesthetic field for maxillary infiltration), cardiovascular parameters (systolic, diastolic, mean arterial pressure; heart rate and electrocardiographic changes), quality of postoperative analgesia (assessed by Visual Analogue Scale, Numerical Rating Scale and number of consumed analgesics) and postoperative complications (infection, bleeding, paresthesia, delayed wound healing) are evaluated and compared.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 256
- Healthy participants: ASA I
- Diabetic type 2 participants: ASA III (HbA1c level < 9%)
- Required a single-root teeth indicated for non-complicated extraction
- Dental diagnosis of periodontal disease, tooth fracture, chronic periapical lesion and root infection
- Subjects give informed written consent
- Pregnancy and lactation
- Allergy to used drugs and food
- Hepatic and/or renal failure
- ASA IV patients
- Tobacco smokers
- History of alcoholism and/or drug abuse and addiction
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Diabetics: L+C maxillary anesthesia L+C maxillary anesthesia Single dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for maxillary infiltration anesthesia Diabetics: L+C mandibular anesthesia L+C mandibular anesthesia Single dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for mandibular block anesthesia Diabetics: L+E maxillary anesthesia L+E maxillary anesthesia Single dose intraoral local anesthesia with 2ml lidocaine (2%)+ epinephrine (1:80.000) for maxillary infiltration anesthesia Diabetics: L+E mandibular anesthesia L+E mandibular anesthesia Single dose intraoral local anesthesia with 2ml lidocaine (2%) + epinephrine (1:80.000) for mandibular block anesthesia Healthy: L+C maxillary anesthesia L+C maxillary anesthesia Single dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for maxillary infiltration anesthesia Healthy: L+C mandibular anesthesia L+C mandibular anesthesia Single dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for mandibular block anesthesia Healthy: L+E maxillary anesthesia L+E maxillary anesthesia Single dose intraoral local anesthesia with 2ml lidocaine (2%)+ epinephrine (1:80.000) for maxillary infiltration anesthesia Healthy: L+E mandibular anesthesia L+E mandibular anesthesia Single dose intraoral local anesthesia with 2ml lidocaine (2%) + epinephrine (1:80.000) for mandibular block anesthesia
- Primary Outcome Measures
Name Time Method Baseline Systolic Blood Pressure Baseline, 0 minutes Duration of Intraoral Local Anesthesia Up to 6 hours after local anesthesia injection Time until cessation in soft tissue numbness
Intensity of Intraoral Local Anesthesia Up to 10 minutes after local anesthesia injection Number of participants who reported values \> 0 after pin-prick testing, using Visual Analogue Scale (VAS) and Numerical Rating Scale (NRS). VAS is represented by line 100 mm long, with one end marked with 0 and words "no pain" , while the other end is marked with 100 and words "the worst pain imanginable". VRS scale is represented by line 100 mm long, marked with numbers from 0 to 10, where 0 corresponds to "no pain", and 10 corresponds to "the worst pain imaginable". For both scales, higher scores represent worse outcomes.
Systolic Blood Pressure at 10 Minutes 10th minute Systolic blood pressure values 5 minutes after local anesthesia injection
Baseline Diastolic Blood Pressure baseline, 0 minutes Diastolic Blood Pressure at 15 Minutes 15th minute Diastolic blood pressure values 10 minutes after local anesthesia injection
Diastolic Blood Pressure at 20 Minutes 20th minute Diastolic blood pressure values 15 minutes after local anesthesia injection
Diastolic Blood Pressure at 35 Minutes 35th minute Diastolic blood pressure values 30 minutes after local anesthesia injection
Baseline Values of Heart Rate baseline, 0 minutes Heart Rate at 20 Minutes 20th minute Heart rate 15 minutes after local anesthesia injection, 20 minutes after baseline measurement
Systolic Blood Pressure at 15 Minutes 15th minute Systolic blood pressure values 10 minutes after local anesthesia injection
Diastolic Blood Pressure at 10 Minutes 10th minute Diastolic blood pressure values 5 minutes after local anesthesia injection
Heart Rate at 10 Minutes 10th minute Heart rate 5 minutes after local anesthesia injection, 10 minutes after baseline measurement
Systolic Blood Pressure at 35 Minutes 35th minute Systolic blood pressure values 30 minutes after local anesthesia injection
Electrocardiogram at 15 Minutes 15th minute ECG 10 minutes after local anesthesia injection, 15 minutes after baseline measurement
Systolic Blood Pressure at 20 Minutes 20th minute Systolic blood pressure values 15 minutes after local anesthesia injection
Heart Rate at 15 Minutes 15th minute Heart rate 10 minutes after local anesthesia injection, 15 minutes after baseline measurement
Ceart Rate at 35 Minutes 35th minute Heart rate 30 minutes after local anesthesia injection, 35 minutes after baseline measurement
Electrocardiogram at 10 Minutes 10th minute ECG 5 minutes after local anesthesia injection, 10 minutes after baseline measurement
Baseline Electrocardiogram baseline, 0 minutes Electrocardiogram at 20 Minutes 20th minute ECG 15 minutes after local anesthesia injection, 20 minutes after baseline measurement
- Secondary Outcome Measures
Name Time Method Local Postoperative Complications 24 hours, 7 days Postoperative paresthesia by clinical examination
Onset of Intraoral Local Anesthesia Up to 10 minutes, until subjective feeling of soft tissue numbnes Evaluated by pin-prick after subjective feeling of soft tissue numbness appeared after local anesthesia injection
Width of Anesthetic Field After Maxillary Infiltration Anesthesia Up to 10 minutes after injection of local anesthesia Soft tissue numbness area determined by pin-prick test after maxillary infiltration anesthesia. Not tested for mandibular ablock anesthesia.
Postoperative Analgesia up to 24 hours after tooth extraction Number of participants who experienced postoperative pain, VAS, NRS
Trial Locations
- Locations (1)
School of Dental Medicine, University of Belgrade
🇷🇸Belgrade, Serbia